Strain name,CP name,Resistance level,#Published,Reference
417N,CP,susceptible,20,Wang21b
417N,Moderna,susceptible,11,Wang21
417N,Moderna_D43,susceptible,12,Wang21b
417N,Pfizer-BioNTech,susceptible,4,Wang21
417N,Pfizer_BNT162b2_D28,susceptible,10,Wang21b
417N + 484K + 501Y(B.1.351 RBD),CP_Titer_GT400,susceptible,6,Wibmer21
417N + 484K + 501Y(B.1.351 RBD),CP_Titer_GT400,partial,7,Wibmer21
417N + 484K + 501Y(B.1.351 RBD),CP_Titer_GT400,resistance,9,Wibmer21
417N + 484K + 501Y(B.1.351 RBD),CP_Titer_LT400,susceptible,6,Wibmer21
417N + 484K + 501Y(B.1.351 RBD),CP_Titer_LT400,partial,10,Wibmer21
417N + 484K + 501Y(B.1.351 RBD),CP_Titer_LT400,resistance,6,Wibmer21
439K,CP_1M,susceptible,3,Shen21
439K,Mod_1M,susceptible,11,Shen21
439K,Moderna,susceptible,11,Wang21
439K,Pfizer-BioNTech,susceptible,4,Wang21
484K,BNT162b2_1M,susceptible,1,Tada21
484K,BNT162b2_1M,partial,4,Tada21
484K,CP,susceptible,10,Tada21
484K,CP,susceptible,6,Wang21b
484K,CP,partial,12,Wang21b
484K,CP,resistance,2,Wang21b
484K,CP_13,susceptible,1,Liu21
484K,CP_29,partial,1,Liu21
484K,CP_35,susceptible,1,Liu21
484K,CP_37,partial,1,Liu21
484K,CP_BNT162b2,susceptible,2,Jangra21
484K,CP_BNT162b2,partial,3,Jangra21
484K,CP_ModerateIgG,susceptible,4,Jangra21
484K,CP_ModerateIgG,partial,5,Jangra21
484K,CP_ModerateIgG,resistance,2,Jangra21
484K,CP_StrongIgG,susceptible,7,Jangra21
484K,CP_StrongIgG,partial,4,Jangra21
484K,CP_weakIgG,susceptible,6,Jangra21
484K,CP_weakIgG,partial,1,Jangra21
484K,CP_weakIgG,resistance,1,Jangra21
484K,Moderna_D43,susceptible,8,Wang21b
484K,Moderna_D43,partial,4,Wang21b
484K,Pfizer_BNT162b2_D28,susceptible,6,Wang21b
484K,Pfizer_BNT162b2_D28,partial,3,Wang21b
484K,Pfizer_BNT162b2_D28,resistance,1,Wang21b
484K,Subject_B_d26,resistance,1,Greaney21
484K,Subject_C_d32,resistance,1,Greaney21
484K,Subject_G_d18,susceptible,1,Greaney21
484K,Subject_I_d26,partial,1,Greaney21
484K + 501Y,CP_BNT162b2_1M,susceptible,20,Xie21b
501Y,BNT162b2_1M,susceptible,5,Tada21
501Y,BNT162b2_2Weeks,susceptible,4,Xie21
501Y,BNT162b2_4Weeks,susceptible,7,Xie21
501Y,CP,susceptible,19,Edara21
501Y,CP,partial,1,Edara21
501Y,CP,susceptible,18,Tada21
501Y,CP,susceptible,18,Wang21b
501Y,CP,partial,2,Wang21b
501Y,CP_1M,susceptible,11,Shen21
501Y,CP_1M,partial,4,Shen21
501Y,CP_BNT162b2_1M,susceptible,20,Xie21b
501Y,Hospitalized_Samples,susceptible,18,Rees-Spear21
501Y,Mild_Samples,susceptible,18,Rees-Spear21
501Y,Mod_1M,susceptible,11,Shen21
501Y,Moderna,susceptible,11,Wang21
501Y,Moderna_D43,susceptible,12,Wang21b
501Y,Pfizer-BioNTech,susceptible,4,Wang21
501Y,Pfizer_BNT162b2_D28,susceptible,10,Wang21b
501Y,mRNA-1273,susceptible,14,Edara21
∆69/70,CP,susceptible,3,Kemp21
∆69/70,CP,susceptible,18,Tada21
∆69/70,CP,susceptible,20,Wang21b
∆69/70,Hospitalized_Samples,susceptible,18,Rees-Spear21
∆69/70,Mild_Samples,susceptible,18,Rees-Spear21
∆69/70,Moderna_D43,susceptible,12,Wang21b
∆69/70,Pfizer_BNT162b2_D28,susceptible,10,Wang21b
∆69/70 + 501Y,CP_1M,susceptible,15,Shen21
∆69/70 + 501Y,CP_BNT162b2_1M,susceptible,20,Xie21b
∆69/70 + 501Y,Mod_1M,susceptible,11,Shen21
∆69/70 + 501Y + 453F,CP_1M,susceptible,12,Shen21
∆69/70 + 501Y + 453F,CP_1M,partial,3,Shen21
∆69/70 + 501Y + 453F,Mod_1M,susceptible,11,Shen21
∆69/70 + 501Y + 570D,BNT162b2_3Weeks,susceptible,15,Collier21
